Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-12

FDA Approved: BIMATOPROST — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for bimatoprost from Alembic Pharmaceuticals Inc., authorizing a generic version of the glaucoma medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)